Johnson & Johnson is a global pharmaceutical, medical devices, and consumer goods company founded more than 120 years ago. Today, Johnson & Johnson touches more than a billion people’s lives each day through health care products and services, corporate giving and employee volunteer efforts.

The family of Johnson & Johnson companies comprise the world’s premier consumer health company, the world’s largest and most diverse medical devices and diagnostics company, the world’s fourth-largest biologics company and the world’s seventh-largest pharmaceuticals company.  Over the past three years, Johnson & Johnson companies provided more than 3.1 million units of medicine to nearly 477,000 U.S. patients.

Johnson & Johnson produces consumer products such as baby care and oral healthcare products, medical device products such as orthopaedic devices and implants, and prescription products in areas such as neuroscience and cardiovascular disease. 

“At Johnson & Johnson, we appreciate the importance of quality healthcare in people’s lives. We also understand that collaboration among key stakeholders, including industry, is essential to make the desired changes in US healthcare,” said Dave Domann, director of future market strategies at Ortho-McNeil Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson. “That’s why we are proud to be a part of the National Priorities Partnership and the efforts underway to transform healthcare and improve patient care and outcomes.”

For more information on Johnson & Johnson, please visit http://www.jnj.com/connect/.